Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 851 to 900 of 2027

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Carfilzomib for previously treated multiple myelomaTA657
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myelomaTA658
Galcanezumab for preventing migraineTA659
Guidance on the use of coronary artery stentsTA71
Swallowable gastric balloon capsule for weight lossHTG561
Human and animal bites: antimicrobial prescribingNG184
Testing strategies for Lynch syndrome in people with endometrial cancerHTG557
Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosisHTG558
Balloon cryoablation for squamous dysplasia of the oesophagusHTG560
Volanesorsen for treating familial chylomicronaemia syndromeHST13
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapyTA655
Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancerTA653
Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancerTA654
SEM Scanner 200 for preventing pressure ulcersHTG556
Rheumatoid arthritis in adults: managementNG100
Behaviour change: digital and mobile health interventionsNG183
Pembrolizumab with axitinib for untreated advanced renal cell carcinomaTA650
Naldemedine for treating opioid-induced constipationTA651
Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphomaTA649
Transcranial magnetic stimulation for auditory hallucinationsHTG555
Neuropathic pain in adults: pharmacological management in non-specialist settingsCG173
Insect bites and stings: antimicrobial prescribingNG182
Axonics sacral neuromodulation system for treating refractory overactive bladderHTG554
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic strokeHTG553
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)TA646
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal)TA647
High-sensitivity troponin tests for the early rule out of NSTEMIHTG552
Anaphylaxis: assessment and referral after emergency treatmentCG134
Surgical site infections: prevention and treatmentNG125
Perioperative care in adultsNG180
Rehabilitation for adults with complex psychosisNG181
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancerTA643
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Gilteritinib for treating relapsed or refractory acute myeloid leukaemiaTA642
Deep brain stimulation for refractory epilepsy in adultsHTG550
Implanted vagus nerve stimulation for treatment-resistant depressionHTG551
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplantTA640
Transcranial magnetic stimulation for obsessive-compulsive disorderHTG548
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney diseaseHTG549
Artificial iris insertion for acquired aniridiaHTG546
Artificial iris insertion for congenital aniridiaHTG547
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Ranibizumab for treating diabetic retinopathy (terminated appraisal)TA637
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)TA634
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)TA635
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)TA636
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasiaHTG545
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test)HTG544

Results per page

  1. 10
  2. 25
  3. 50
  4. All